[Multi-drug resistant tuberculosis (MDRTB)]

Area of Science:

• Infectious Diseases
• Microbiology
• Public Health

Context:

• Multidrug-resistant tuberculosis (MDRTB) poses a significant global health challenge, often resulting from treatment failures and nosocomial spread.
• The emergence of acquired and primary MDRTB necessitates a re-evaluation of current treatment and prevention strategies within healthcare settings.
• Limited isolation facilities in tuberculosis wards, particularly in Japan, exacerbate the risk of transmission.

Purpose:

• To elucidate the clinical development of MDRTB, including acquired and primary forms.
• To propose effective prevention and control measures for MDRTB spread within hospitals.
• To highlight the urgent need for rapid diagnostic tools and adequate isolation infrastructure.

Summary:

• MDRTB develops through treatment failure (leading to acquired resistance) and direct contagion (leading to primary MDRTB).
• A case report illustrates the dangers of monotherapy, contributing to drug resistance.
• Nosocomial outbreaks, including re-infections, underscore the contagiousness of MDRTB.
• Strict isolation of smear-positive MDRTB patients and all smear-positive tuberculosis patients is crucial.
• Rapid detection of rifampicin resistance via gene analysis is vital given insufficient isolation rooms.

Impact:

• Provides a framework for understanding MDRTB pathogenesis and transmission dynamics.
• Offers practical recommendations for hospital infection control to mitigate MDRTB outbreaks.
• Emphasizes the critical role of rapid diagnostics and infrastructure in combating MDRTB.
• Informs public health policy regarding tuberculosis management and infection control in healthcare facilities.